Yes. Quincy Bioscience has research laboratories at the University of Wisconsin-Milwaukee. In our foundational trials, apoaequorin demonstrated over 50% brain cell protection versus the control group. A recent memory study showed Prevagen significantly improved cognitive function compared to placebo. The findings of this research were presented to the Alzheimer’s Association International Conference.
